|This message contains images. If you don't see images, click here to view.|
Advertise in this news brief.
July 12-13, 2014
The Breakers, Palm Beach, Florida
It's not too late. You can still register onsite! You don't want to miss these great topics and speakers scheduled for the FSP 2014 Summer Anatomic Pathology Conference!
OIG issues fraud alert for physician-lab relationships
The Department of Health and Human Services Office of the Inspector General recently issued a special fraud alert that singles out the laboratory-referring physician relationship for its focused attention. The OIG has repeatedly emphasized that a lab providing free or below-market goods or services to a physician who is a source of referrals, or paying a physician more than fair market value for his or her services, could constitute illegal remuneration under the federal anti-kickback statute. In light of this special fraud alert, physicians and laboratories should review their compensation arrangements.
Growing shortage of clinical training sites challenges medical schools
What has appeared to be solid progress toward growing an adequate U.S. health care workforce could be derailed by an escalating shortage of clinical training sites to accommodate many of those learners. That's the crux of the message delivered in a recently released report titled Recruiting and Maintaining U.S. Clinical Training Sites: Joint Report of the 2013 Multi-Discipline Clerkship/Clinical Training Site Survey.
Clinician's 'primer' to genome and exome sequencing published
Medical News Today
Some might question whether genome sequencing — and its cut-down version exome sequencing — are ready to move from the lab to the clinic. Experts warn that physicians do not know enough about genetics to understand the strengths and weaknesses of such tools. But clinicians have already ordered several thousand tests — particularly to help with cases of rare childhood diseases — suggesting that, ready or not, the technology has already entered the realm of general medical practice.
Could a new blood test predict breast cancer risk?
Researchers believe they may have a new way to test a woman's risk for breast cancer, even if she doesn't have an inherited genetic mutation. The test looks not for mutations, but for changes to how DNA functions — in this case, the BRCA1 breast cancer gene.
The FDA may not have approved the lab test to diagnose your disease
If you get a test to diagnose a disease, you might assume that the screening has been cleared by federal regulators to make sure it's safe and accurate. But that isn't always the case, and some lawmakers say labs need more oversight to protect patients. Whether a test needs approval from the Food and Drug Administration depends on where it comes from. Tests from manufacturers get approved before they can reach the market, but those created by laboratories don't, according to a letter from five Senate Democrats urging more oversight.
Consumers may soon have a home blood collection kit to monitor, quantify damage to their DNA
It might be coming soon to a pharmacy or other retail store near you: a medical laboratory test kit allows consumers to test themselves for damaged DNA. This bold new world for genetic testing is the vision of a new company in San Francisco called Exogen Biotechnology. This startup business was co-founded by Sylvain Costes, Ph.D., a nuclear engineer who serves as Exogen's Chief Executive Officer, and Jonathan Tang, Ph.D., a bioengineer. Their team is developing a blood test that will enable consumers to monitor their own DNA damage and take actions to reverse the damage.
Time of day crucial to accurately test for diseases, new research finds
A new study published in the journal PNAS (Proceedings of the National Academy of Sciences) has found that time of day and sleep deprivation have a significant effect on our metabolism. The finding could be crucial when looking at the best time of day to test for diseases such as cancer and heart disease, and for administering medicines effectively.
Family history is 'a bigger risk factor than lifestyle' for some cancers
Medical News Today
A Swedish study of nearly 71,000 adopted people has used data from both their natural and adoptive parents to find that family history is a greater risk factor than lifestyle for developing breast, prostate or colorectal cancer. The genetic factors behind these three major cancers are well established, but this large survey of data published in the European Journal of Cancer has looked a unique group of people in a bid to disentangle familial risk from environmental factors.
Disclaimer: The authors, editors, and the Florida Society of Pathologists (FSP) Executive Committee affiliated with "Florida Pathology Today" e-Newsletter cannot and do not warrant the completeness, accuracy, non-infringement, merchantability, timeliness or fitness for a particular purpose of the information or views contained within this publication, or available through the links provided within articles contained within this publication.
FSP has no control over and does not officially endorse the content of the information available on the links contained in the "Florida Pathology Today" or links imbedded in articles within the "Florida Pathology Today." These links are provided as a courtesy only. Linked sites are not a part of the "Florida Pathology Today." The owners of those linked sites, and not FSP, own the intellectual property rights to the material on the linked sites. FSP cannot certify the accuracy of material published on linked sites. Additionally, the contents of this e-Newsletter and the above referenced links, including any advice, suggestions, and/or recommendations have NOT been generated as part of any professional evaluation.
The authors, editors, webmasters, and the FSP Board of Directors affiliated with the "Florida Pathology Today" e-Newsletter shall not be liable to anyone for any loss or injury caused in whole or in part by its negligence or contingencies beyond its control in procuring, compiling, interpreting, reporting or delivering this e-Newsletter and any information included in this e-Newsletter.
Under no circumstances will the authors, editors, webmasters, and the FSP Board of Directors affiliated with the "Florida Pathology Today" be liable to you or anyone else for any decision made or any action taken by you or anyone else in reliance on such information or view, or for any incidental, consequential, special, or similar damages even if advised of the possibility of such damages.
The above warranties are the only warranties of any kind either expressed or implied, including warranties of merchantability or fitness for any particular purpose.
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063